Agree. When Brilacidin hits a mainstream press outlet lots more eyes will be on us in a flash. May be as soon as bottomline results release... someone deciding to do a more in depth compare/contrast with B and the competition.
Below a recent -- 10.29.14 -- Rx-ist targeted article on current ABSSSI meds: Vibativ, Dalvance, Orbactiv, and Sivextro
Outstanding TOB ! Just like everything else you do. Thanks Pal and the Author seems very interested in following up and learning more about Brilacidin. Great Work young man !